GW Pharmaceuticals PLC is engaged in the research, development and commercialisation of cannabinoid prescription medicines using botanical extracts derived from the Cannabis Sativa plant. This is an ADR of a company that does not have its stock publicly traded anywhere else in the world.
$214.91 +0.74 (0.35%)
As of 03/05/2021 15:59:48 EST IEX book CBOE book
2021 © Stock Market MBA, Inc.